Interruption of the CCL2–CCR2 axis can suppress EMT and prostate cancer cell migration and invasion, providing a critical mechanism linking CCL2 and cancer metastasis [19,22,23,24,27,28]. The gene discussed is CCL2; the disease is prostate carcinoma.